Glaxosmithkline Pharmaceuticals consolidated net profit declines 84.79% in the September 2020 quarter

Sales decline 0.31% to Rs 879.32 crore

Net profit of Glaxosmithkline Pharmaceuticals declined 84.79% to Rs 76.47 crore in the quarter ended September 2020 as against Rs 502.75 crore during the previous quarter ended September 2019. Sales declined 0.31% to Rs 879.32 crore in the quarter ended September 2020 as against Rs 882.02 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales879.32882.02 0 OPM %23.3022.00 -PBDT213.02208.97 2 PBT191.06186.27 3 NP76.47502.75 -85

Powered by Capital Market - Live News